phase readout
saveNCT06693765: A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Renal Impairment, End-stage Kidney Disease, Healthy Participants
view source ↗
comments(0)
5-min edit window · permanent after that